Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer
J. Clin. Invest. Ahmed Boucharaba, et al. 114:1714
doi:10.1172/JCI22123 [Go to this article.]

Problems with a PDF?